Результаты поиска

Этап II - испытание параллельной химиорадиотерапии с использованием L-аспарагиназы и MIDLE химиотерапии для недавно диагностированной стадии I/II экстранодал NK/T-клеток лимфомы носового типа (CISL-1008).

Всего 372 Иксоды рицины тикают101 женщины, 122 мужского пола; и 149 Нимфы), собранные с помощью пометок 6 В зависимости от культуры были изучены смешанные лесные массивы восточной Польши на предмет наличия внутренних отрицательных бактерий, помимо бурдорфери Борелия. Галочка для взрослых была изучена в пулах 2 Каждый образец и каждый имфл были изучены в пулах 3-5 Каждый образец. Тики были дезинфицированы в 70 % этанол и гомогенизированный 0.85% NaCl. Разбавленный гомогенат был привит на 3 Виды агарной среды: буферная добыча дрожжей из древесного угля (BCYE-alpha) для изоляции стойко-отрицатель

The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside.

The mTOR pathway plays a central role in many cellular processes, such as cellular growth, protein synthesis, glucose, and lipid metabolism. Aberrant regulation of mTOR is a hallmark of many cancers, including hematological malignancies. mTOR inhibitors, such as Rapamycin and Rapamycin analogs (Rapalogs), have become a promising class of agents to treat malignant blood diseases-either alone or in combination with other treatment regimens. This review highlights experimental evidence underlying the molecular mechanisms of mTOR inhibitors and summarizes their evolving role in the treatment of he

Совпадение в полном тексте источника
… These effects lead to cell cycle arrest in the G1 phase, therefore also known as Cell Cycle Inhibitor-779 (CCI-779). In August 2007, FDA approved temsirolimus as a first-line treatment for advanced renal cancer. … As for chronic lymphocytic leukemia (CLL), Decker et al. found that Rapamycin mediates the arrest of B cells of CLL in G1 phase ( 85 ). Three cases of lymphoproliferative diseases after transplantation have been successfully treated with rituximab and Rapamycin ( 86 ). …

Каннабиноиды в раке: Молекулярные механизмы смерти клеток и возможности перевода.

Каннабиноиды представляют собой терпенофенолические соединения, полученные из Cannabis sativa L., которые осуществляют широкий спектр биологической и фармакологической деятельности. Растущие данные свидетельствуют об их потенциале как модуляторов развития рака, особенно посредством подавления роста клеток опухоли, ангиогенеза и метастаза в различных моделях опухоли. В настоящем обзоре содержится всеобъемлющий обзор молекулярных механизмов, с помощью которых природные и синтетические каннабиноиды вызывают регулируемую смерть раковых клеток. Текущие данные свидетельствуют о том, что каннабиноиды

Совпадение в полном тексте источника
… In addition, 10 μmol/L JWH-133 resulted in a 58% and 48% inhibition in the proliferation of MDA-MB231 and MDAMB468 cells, respectively, while resulting in a G0/G1 phase cell cycle arrest in MDA-MB231 cells and a significant 40% induction of apoptosis in JWH-133-treated tumors relative to control tumors … For instance, it has been shown that although CBD elevated the proportion of CD19-CAR T cells in the sub-G1 phase in the cell cycle, the antitumor effect and cytokine secretion of those cells were not affected by CBD treatment in hematologic malignancies [ 178 ]. …

Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies.

Polyphenols are one of the largest plant-derived natural product and they play an important role in plants' defense as well as in human health and disease. A number of them are pleiotropic molecules and have been shown to regulate signaling pathways, immune response and cell growth and proliferation which all play a role in cancer development. Hematological malignancies on the other hand, are cancers of the blood. While current therapies are efficacious, they are usually expensive and with unwanted side effects. Thus, the search for newer less toxic agents. Polyphenols have been reported to po

Совпадение в полном тексте источника
… These are the interphase (the S phase, where cells duplicate their DNA contents through DNA replication; the G1 phase, where cells synthesize mRNA and proteins in preparation for mitosis; G2 phase, a period of rapid protein synthesis. … Thus, G0/G1 phase and cyclin D1 are potential targets for the management of hematological malignancies ( 202 , 203 ). Polyphenols and polyphenol-rich extracts have equally shown potential as cell cycle inhibitors ( 204 , 205 ). …

Effects of Carbon Nanomaterials and Aloe vera on Melanomas-Where Are We? Recent Updates.

Melanoma is an aggressive skin cancer that affects approximately 140,000 people worldwide each year, with a high fatality rate. Available treatment modalities show limited efficacy in more severe cases. Hence, the search for new treatment modalities, including immunotherapies, for curing, mitigating, and/or preventing cancer is important and urgently needed. Carbon nanoparticles associated with some plant materials, such as Aloe vera, have shown appealing antineoplastic activity, derived mainly from the compounds aloin, aloe-emodin, barbaloin acemannan, and octapeptide, thus representing new p

Совпадение в полном тексте источника
… The dichloromethane (CH 2 Cl 2 ) extract of Aloe vera inhibited the growth of Ehrlich ascites cells by decreasing DNA synthesis and inducing the accumulation of cells in the G1 phase of the cell replicative cycle [ 46 , 59 ]. …

Defining diagnostic trajectories in patients with podocytopathies.

Podocytopathies are glomerular disorders in which podocyte injury drives proteinuria and progressive kidney disease. They encompass a broad spectrum of aetiologies, resulting in pathological pictures of minimal-changes, focal segmental glomerulosclerosis, diffuse mesangial sclerosis or collapsing glomerulopathy. Despite improvement in classifying podocytopathies as a distinct group of disorders, the histological definition fails to capture the relevant biological heterogeneity underlying each case, manifesting as extensive variability in disease progression and response to therapies. Increasin

Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy.

Long noncoding RNAs (lncRNAs) constitute a distinctive subset of RNA molecules with limited protein-coding potential, which exert crucial impacts on various biological activities. In the context of cancer, dysregulated lncRNAs function as essential regulators that affect tumor initiation and malignant progression. These lncRNAs serve as competitive endogenous RNAs (ceRNAs) through sponging microRNAs and regulating the expression of targeted genes. Moreover, they also directly bind to RNA-binding proteins, which can be integrated into a complex mechanistic network. E2F1, an extensively studied

Совпадение в полном тексте источника
… interacting with E2F1 to increase CD151 expression through activating the AKT/mTOR/cyclinD1 signaling pathway | Promotes radiotherapy resistance | Xiao et al. (2022) EGFR-AS1 | Up | EGFR-AS1 | Gastric cancer | EGFR-AS1 promotes TUBA1C expression, which aggravates E2F1 expression and facilitates the G1 … Elevated EGFR-AS1 promoted GC growth and metastasis by targeting TUBA1C, which aggravated E2F1 expression and facilitated the G1 phase to the S phase transition ( Wang H. et al., 2023 ). Moreover, lncRNA might sponge miRNA to rescue the E2F1 inhibition, thus promoting disease development. …

Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation.

Pancreatic neuroendocrine tumors (PNETs) are characterized by dysregulated signaling pathways that are crucial for tumor formation and progression. The efficacy of traditional therapies is limited, particularly in the treatment of PNETs at an advanced stage. Epigenetic alterations profoundly impact the activity of signaling pathways in cancer development, offering potential opportunities for drug development. There is currently a lack of extensive research on epigenetic regulation in PNETs. To fill this gap, we first summarize major signaling events that are involved in PNET development. Then,

Совпадение в полном тексте источника
… Inhibition of HDACs induced elevated expression of CDK inhibitors, resulting in the blockade of the cell cycle at the G1 phase and disruption of the G1/S transition. …

Generation and characterization of mAb 61H9 against junctional adhesion molecule-a with potent antitumor activity.

Junctional adhesion molecule-A (JAM-A) is an adhesion molecule that exists on the surface of certain types of cells, including white blood cells, endothelial cells, and dendritic cells. In this study, the cDNA sequences of JAM-A-Fc were chemically synthesized with optimization for mammalian expression. Afterward, we analyzed JAM-A protein expression through transient transfection in HEK293 cell lines. Mice were immunized with JAM-A-Fc protein, and hybridoma was prepared by fusing myeloma cells and mouse spleen cells. Antibodies were purified from the hybridoma supernatant and four monoclonal s

Совпадение в полном тексте источника
… Notably, 61H9G4 arrested cells in the G0/G1 phase, which may promote cell apoptosis ( P < 0.01 or P < 0.001) ( Fig. 4C ). Meanwhile, we analyzed scratch wound healing, and calculated the relative migration distance at 0, 6, 24, and 48 h. … CyclinD1 is a key protein in regulating the G1 phase of the cell cycle, and overexpression of CyclinD1 is closely related to the occurrence and development of malignant tumors. BCL2 can inhibit apoptosis occurrence. …

Unraveling the Anticancer Effect of Curcumin and Resveratrol.

Resveratrol and curcumin are natural products with important therapeutic properties useful to treat several human diseases, including cancer. In the last years, the number of studies describing the effect of both polyphenols against cancer has increased; however, the mechanism of action in all of those cases is not completely comprehended. The unspecific effect and the ability to interfere in assays by both polyphenols make this challenge even more difficult. Herein, we analyzed the anticancer activity of resveratrol and curcumin reported in the literature in the last 11 years, in order to unr

Совпадение в полном тексте источника
… This inhibitory effect exhibited a direct relationship with a decreased activity in the glycolysis pathway and may be the cause of cell cycle arrest in G0/G1 phase according authors observations [ 83 ]. … The percentage of sh-CKD2-transfected HCT116 colon cancer cells in G1 phase was higher after curcumin treatment that those of control groups. …

Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy.

Despite the availability of technological advances in traditional anti-cancer therapies, there is a need for more precise and targeted cancer treatment strategies. The wide-ranging shortfalls of conventional anticancer therapies such as systematic toxicity, compromised life quality, and limited to severe side effects are major areas of concern of conventional cancer treatment approaches. Owing to the expansion of knowledge and technological advancements in the field of cancer biology, more innovative and safe anti-cancerous approaches such as immune therapy, gene therapy and targeted therapy a

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.

BRAFV600E alterations are prevalent across multiple tumors. Here we present final efficacy and safety results of a phase 2 basket trial of dabrafenib (BRAF kinase inhibitor) plus trametinib (MEK inhibitor) in eight cohorts of patients with BRAFV600E-mutated advanced rare cancers: anaplastic thyroid carcinoma (n = 36), biliary tract cancer (n = 43), gastrointestinal stromal tumor (n = 1), adenocarcinoma of the small intestine (n = 3), low-grade glioma (n = 13), high-grade glioma (n = 45), hairy cell leukemia (n = 55) and multiple myeloma (n = 19). The primary endpoint of investigator-assessed o

Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches.

In the last few years, substantial progress has been made in the treatment of ovarian cancer, with increased knowledge about the biology of the disease. Ovarian cancer is a neoplasm strongly linked to defects in DNA repair mechanisms, where deficiency in the homologous recombination (HR) system results in a better response of ovarian cancers to therapy, whether platinum-based chemotherapy, anthracyclines, or poly (ADP-ribose) polymerase (PARP) inhibitors. More recently, it has been demonstrated that different ovarian cancer histotypes may have different immunogenicity. Interestingly, defects i

Совпадение в полном тексте источника
… Thus, HIPEC causes cell cycle arrest thanks to CDKN1A expression, which in response to DNA damage through p53 activation, binds and inhibits the CDK2/cyclin E complex, preventing the phosphorylation of Rb and thus arresting cancer cells in the G1 phase [ 81 ]. …

Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells.

[Figure: see text] Multiple myeloma (MM) remains an intractable hematological malignancy, despite recent advances in anti-MM drugs. Here, we show that role of PDZ binding kinase (PBK) in MM tumor growth. We identified that interleukin-6 (IL-6) readily increases PBK expression. Kaplan-Meier analysis showed that the MM patients with higher expression of PBK have a significant shorter survival time compared with those with moderate/lower expression of PBK. Knockout of PBK dramatically suppressed in vivo tumor growth in MM cells, while genome editing of PBK changing from asparagine to serine subst

Совпадение в полном тексте источника
… The percentages of cells in the sub-G1 phase were measured using FlowJo software (Tree Star, Inc., Ashland, OR). …

Gambogic Acid as a Candidate for Cancer Therapy: A Review.

Gambogic acid (GA), a kind of dry resin secreted by the Garcinia hanburyi tree, is a natural active ingredient with various biological activities, such as anti-cancer, anti-inflammatory, antioxidant, anti-bacterial effects, etc. An increasing amount of evidence indicates that GA has obvious anti-cancer effects via various molecular mechanisms, including the induction of apoptosis, autophagy, cell cycle arrest and the inhibition of invasion, metastasis, angiogenesis. In order to improve the efficacy in cancer treatment, nanometer drug delivery systems have been employed to load GA and form mice

Совпадение в полном тексте источника
… Among them, G2/M arrest was induced by GA via decreasing the levels of phospho-cdc2 (Thr 161) and cdc25B in MG63 cells. 56 Besides, Chen et al demonstrated that G2/M arrest in MCF-7 cells was induced by GA depolymerization of microtubules. 10 GA could induce the G0/G1 phase cell cycle arrest and apoptosis … in human chronic myelogenous leukemia cell line K562 cells via downregulating the expression of SRC-3 and inhibiting the Akt pathway. 11 Similarly, GA treatment induced the G0/G1 phase arrest in U2OS cells was associated with a decrease in phospho-GSgsK3-β (Ser9) and the expression of cyclin D1. 56 …

Проверка генотипов чечевиц на предмет выявления болезни стволового ствола и молекулярная идентификация причинно-следственного организма.

Во время сезона сбора урожая 2019-20, 2020-21, и 2021-22С помощью Alpha-Lattice Design с помощью Alpha-Lattice Genoтипы чечевиц были скринингированы на Stemphilium blight. three Репликации в Исследовательском центре Пульса, БАРИ, Ишурди, Pabna-6620 в естественных и искусственных эпифитотических условиях. В случае искусственного инокулума искусственные инокулумы были разбрызганы на 1.3 × 105 Споры/мл концентрации споров для прививки споров на экспериментальных участках. Данные о серьезности заболевания были зарегистрированы следующим образом: 1-9 Кроме того, была произведена оценка шкалы рейтин

Thiostrepton Suppresses the Progression of Rhabdomyosarcoma by Inhibiting the PI3K-AKT Signaling Pathway.

Rhabdomyosarcoma (RMS), the most common pediatric soft tissue sarcoma with 5-year survival below 30% in high-risk/metastatic cases, was investigated through integrated bioinformatics analysis (identifying 269 conserved differentially expressed genes in GEO datasets GSE28511/GSE141690) and experimentally validated thiostrepton (TST), a ribosomal-targeting antibiotic, as a potent therapeutic candidate via Connectivity Map analysis (p p AKT, JAK, CDKs). This was confirmed by PI3K activator 740 Y-P rescue experiments, which partially reversed the effects of TST (p < 0.05). These findings establish

Совпадение в полном тексте источника
… (A) Percentage of cells in the G0‐G1 phase of the flow cytometry on A204 cells treated with different concentrations of TST (5 or 10 μmol/L) and DMSO. (B) Percentage of cells in the G0‐G1 phase of the flow cytometry on RD cells treated with different concentrations of TST (5 or 10 μmol/L) and DMSO. …

CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas.

We aimed to elucidate the diagnostic potential of the C-X-C motif chemokine receptor 4 (CXCR4)-directed positron emission tomography (PET) tracer 68Ga-Pentixafor in patients with poorly differentiated neuroendocrine carcinomas (NEC), relative to the established reference standard 18F-FDG PET/computed tomography (CT). In our database, we retrospectively identified 11 treatment-naïve patients with histologically proven NEC, who underwent 18F-FDG and CXCR4-directed PET/CT for staging and therapy planning. The images were analyzed on a per-patient and per-lesion basis and compared to immunohistoch

Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategies.

Clonal hematopoiesis (CH) is defined by the clonal expansion of hematopoietic stem and progenitor cells harboring somatic mutations that confer a fitness advantage. CH is common with advancing age and becomes nearly ubiquitous in middle age. Although typically asymptomatic, CH is associated with an increased risk of hematologic malignancies particularly myeloid neoplasms (MN), diverse non-malignant conditions, and all-cause mortality. Over the past decade, research has provided major insights into the origins of CH. In addition to aging, CH is promoted by environmental exposures, inherited gen

The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers.

Cancers are generally recognized as the leading cause of death and a predominant barrier to prolonging life expectancy in both developed and developing countries. Emodin is a typical anthraquinone derivative from various plants that exhibits a wide spectrum of biological activities, such as anticancer, antibacterial, hepatoprotective and anti-inflammatory activities. Much previous preclinical evidence has demonstrated that emodin exhibits reliable effects on several cancer types, including lung cancer, liver cancer, colon cancer, breast cancer, pancreatic cancer, leukemia, cervical cancer, and

Совпадение в полном тексте источника
… Chen et al . reported that emodin inhibited proliferation and cell colony formation and induced cell apoptosis due to G0/G1 phase arrest in HL-60/ADR cells 180 . … In addition, emodin also caused G0/G1 phase arrest in Tca8113 cells and reduced the expression of CDK2, Cyclin E and P21 216 . …